Idiosyncratic reactions to phenytoin

Clinical Pediatrics
|March 1, 1987
PubMed

Insights

Pediatric patients on phenytoin may experience severe idiosyncratic reactions, including fever, rash, and hepatitis. Early recognition and drug discontinuation are crucial to prevent life-threatening outcomes.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Toxicology
  • Dermatology

Background:

  • Phenytoin is a widely used antiepileptic drug in pediatric populations.
  • Idiosyncratic drug reactions can present with diverse and severe clinical manifestations.
  • Prompt identification of adverse drug events is critical for patient safety.

Observation:

  • A case report and literature review identified 17 pediatric patients (2.5-21 years) with phenytoin-induced idiosyncratic reactions.
  • Common symptoms included fever (82%), rash (94%), lymphadenopathy (94%), and hepatitis (94%).
  • Eosinophilia was noted in 76% of cases, suggesting an immune-mediated process.

Findings:

  • The observed constellation of symptoms frequently mimics common pediatric infections.
  • Hepatitis and significant systemic inflammation are key features of this reaction.
  • High prevalence of rash, fever, lymphadenopathy, and hepatitis highlights the severity.

Implications:

  • Pediatricians must maintain a high index of suspicion for phenytoin hypersensitivity in patients presenting with these symptoms.
  • Early discontinuation of phenytoin is essential to avert severe complications and potential mortality.
  • This reaction underscores the importance of pharmacovigilance in pediatric epilepsy management.

Related Concept Videos

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...